protein

Recombinant Mouse Fibroblast Growth Factor-9

MBS142226

0.002 mg

140 USD

Recombinant Protein

Recombinant Mouse Fibroblast Growth Factor-9

Fibroblast Growth Factor-9

FGF 9 Mouse; Fibroblast Growth Factor-9 Mouse Recombinant; GAF (Glia-activating factor); HBGF-9; MGC119914; MGC119915; FGF-9

fibroblast growth factor 9; Fibroblast growth factor 9; fibroblast growth factor 9; FGF-9; GAF; HBGF-9; elbow knee synostosis; glia activating factor; glia-activating factor; fibroblast growth factor 9; Glia-activating factor; GAF; HBGF-9

mFGF 9

Fgf9; Fgf9; Eks; Fgf-9; FGF-9; GAF

FGF9_MOUSE

E Coli

208

The sequence of the first five N-terminal amino acids was determined and was found to be Pro-Leu-Gly-Glu-Val.

Greater than 95.0% as determined by(a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.

The protein was lyophilized from 10mM Tris, pH 8.0, 0.15M Amonium Sulfate. Sterile Filtered White lyophilized (freeze-dried) powder.

Lyophilized Fibroblast Growth Factor-9 although stable at room temperature for 3 weeks, should be stored desiccated below -18 degree C. Upon reconstitution FGF9 Mouse Recombinant should be stored at 4 degree C between 2-7 days and for future use below -18 degree C.For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Please prevent freeze-thaw cycles.

Solubility: It is recommended to reconstitute the lyophilized Fibroblast Growth Factor 9 in sterile 18M Omega -cm H2O not less than 100 ug/ml, which can then be further diluted to other aqueous solutions. Biological Activity: The ED50, calculated by the dose-dependant proliferation of BAF3 cells expressing FGF receptors (measured by 3H-thymidine uptake) is <0.5 ng/ml, corresponding to a specific activity of 2MU/mg.

CYTOKINES AND GROWTH FACTORS; Growth Factors; Fibroblast Growth Factor

Description: Fibroblast Growth Factor-9 Mouse Recombinant produced in E Coli is a single, non-glycosylated, polypeptide chain containing 205 amino acids and having a molecular mass of 23308 Dalton.The FGF-9 Mouse Recombinant is purified by proprietary chromatographic techniques. Introduction: Rat and mouse FGF-9 show a very high homology to human FGF-9. The transcripts for FGF-9 have been found in brain and in kidney tissue. Fibroblast Growth Factor-9 is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. FGF9 was isolated as a secreted factor that exhibits a growth-stimulating effect on cultured glial cells. In nervous system, this protein is produced mainly by neurons and may be important for glial cell development. Expression of the mouse homolog of this gene was found to be dependent on Sonic hedgehog (Shh) signaling. Mice lacking the homolog gene displayed a male-to-female sex reversal phenotype, which suggested a role in testicular embryogenesis Fibroblast Growth Factor 9 may have a role in glial cell growth and differentiation during development, gliosis during repair and regeneration of brain tissue after damage, differentiation and survival of neuronal cells, and growth stimulation of glial tumors.

110625633

NP_038546.2

NM_013518.4

P54130

23,414 Da

Activated Point Mutants Of FGFR2 Pathway (1111339); Adaptive Immune System Pathway (1110669); Constitutive PI3K/AKT Signaling In Cancer Pathway (1111361); DAP12 Interactions Pathway (1110771); DAP12 Signaling Pathway (1110772); Disease Pathway (1111319); Downstream Signal Transduction Pathway (1110451); Downstream Signaling Events Of B Cell Receptor (BCR) Pathway (1110683); Downstream Signaling Of Activated FGFR Pathway (1110382); ESC Pluripotency Pathways (198374)

FGF9: Plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. May have a role in glial cell growth and differentiation during development, gliosis during repair and regeneration of brain tissue after damage, differentiation and survival of neuronal cells, and growth stimulation of glial tumors. Defects in FGF9 are the cause of multiple synostoses syndrome type 3 (SYNS3). Multiple synostoses syndrome is an autosomal dominant condition characterized by progressive joint fusions of the fingers, wrists, ankles and cervical spine, characteristic facies and progressive conductive deafness. Belongs to the heparin-binding growth factors family. Protein type: Cytokine. Cellular Component: extracellular space; cell; cytoplasm; extracellular region; basement membrane; intracellular. Molecular Function: heparin binding; growth factor activity; fibroblast growth factor receptor binding; receptor binding. Biological Process: negative regulation of Wnt receptor signaling pathway; positive regulation of transcription, DNA-dependent; multicellular organismal development; embryonic skeletal development; negative regulation of transcription from RNA polymerase II promoter; positive regulation of vascular endothelial growth factor receptor signaling pathway; positive regulation of activin receptor signaling pathway; positive regulation of MAPKKK cascade; cell-cell signaling; protein import into nucleus; male sex determination; positive regulation of cell proliferation; positive regulation of mesenchymal cell proliferation; positive regulation of smoothened signaling pathway; chondrocyte differentiation; angiogenesis; cell differentiation; regulation of timing of cell differentiation; embryonic gut development; positive regulation of cardiac muscle cell proliferation; embryonic limb morphogenesis; inner ear morphogenesis; fibroblast growth factor receptor signaling pathway; male gonad development; osteoblast differentiation; positive regulation of cell division; positive regulation of epithelial cell proliferation; lung development

0.002 mg

140 USD

0.01 mg

205

1 mg

3410